Croda invests further in Cutitronics

By Deanna Utroske

- Last updated on GMT

© Getty Images / (AndreyPopov)
© Getty Images / (AndreyPopov)
The beauty ingredient maker announced this week that it is putting even more money into Cutitronics, a health tech company that’s developing consumer skin care devices to deliver customized product and to gather data. The companies are at work on a devise that seemingly has the potential to merge clinical and consumer testing into a single enterprise.

Croda first invested in Cutitronics in mid-2017, becoming a minority stakeholder and adding company president of personal care in North America Sandra Breene to the Cutitronics board, as Cosmetics Design reported​ at the time.

“To be part of Cutitronics at such an exciting time in their development is wonderful,” ​says Breene in a press release announcing the additional investment.

“We believe that a novel device such as CutiTron, and the wealth of data around skin care routines and consumer behaviour it will provide, will be invaluable for us in creating innovative, sustainable next generation ingredients for the personal care industry.”

Dollars

Croda has not shared financial details of the partnership but is clear in stating that the company, even after this latest investment, remains a minority shareholder in Cutitronics.

Cutitronics founder and CEO David Heath, does suggest however that the tech maker is now in a better position to realize its objectives:“Today’s announcement marks a milestone in Cutitronics’ journey,” ​says Heath in the press release issued Wednesday.

“We are excited to be able to put real pace behind our ambitious plans to grow our team and develop our suite of technologies.  The support we have received from Croda to date has been invaluable. Continuing this partnership will assist us in progressing our ambitious plans for 2019 and beyond.”

Devices

The next steps for Croda and Cutitronics is a fully realized, customizable commercial device, according to the release. The devise known as a CutiTron is due for updates, compliance testing, and a pilot manufacturing round.

The CutiTron assesses skin care needs, prepares the skin for efficient skin care application, and doses out the recommended product. “CutiTron’s further development follows extensive collaboration with skin and beauty care companies,” ​emphasizes the press release.

---

DeannaUtroske_Editor_CosmeticsDesign

Deanna Utroske, CosmeticsDesign.com Editor, covers beauty business news in the Americas region and publishes the weekly Indie Beauty Profile column, showcasing the inspiring work of entrepreneurs and innovative brands.

Related news

Show more

Related products

show more

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us

Products

View more

Podcast

Beauty 4.0 Podcast